Coronavirus: Anticoagulant Therapy May Improve COVID-19 Survival Rate
According to a report by the Fox News website on August 26, 2020, an observational study conducted by a research team in Mount Sinai, New York, showed that in patients infected with the new coronavirus, a therapeutic dose (the author of the research report defines it as a full dose) The risk of death is reduced by 50% for people who use coagulation drugs or blood thinners and those who use preventive doses, that is, lower doses of blood thinning drugs, and the need for tracheal intubation is also reduced by 30%.